<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2010-6-537-546</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-469</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>АНТИТЕЛА К ЦИТОПЛАЗМЕ НЕЙТРОФИЛОВ КАК МАРКЕР НЕБЛАГОПРИЯТНОГО ТЕЧЕНИЯ НЕСПЕЦИФИЧЕСКОГО ЯЗВЕННОГО КОЛИТА</article-title><trans-title-group xml:lang="en"><trans-title>ANTIBODIES TO THE CYTOPLASM OF NEUTROPHILS: A MARKER OF UNFAVORABLE CLINICAL  COURSE IN NON-SPECIFIC ULCERATIVE COLITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харитонов</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kharitonov</surname><given-names>A. G.</given-names></name></name-alternatives><email xlink:type="simple">autoimmun@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кондрашина</surname><given-names>Э. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kondrashina</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">autoimmun@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барановский</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Baranovsky</surname><given-names>A. Yu.</given-names></name></name-alternatives><email xlink:type="simple">autoimmun@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булгакова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulgakova</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">autoimmun@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лапин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lapin</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">autoimmun@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тотолян</surname><given-names>Арег А.</given-names></name><name name-style="western" xml:lang="en"><surname>Totolian</surname><given-names>Areg A.</given-names></name></name-alternatives><email xlink:type="simple">autoimmun@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>СПб МАПО, кафедра гастроэнтерологии, Санкт-Петербург</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>СПбГМУ им. акад. И.П. Павлова, Научно-методический центр по молекулярной медицине, Лаборатория &#13;
диагностики аутоиммунных заболеваний, Санкт-Петербург</institution><country>Russian Federation</country></aff><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>НИИ эпидемиологии и микробиологии им. Пастера Роспотребнадзора, Санкт-Петербург</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg Pasteur Institute of Epidemiology and Microbiology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>22</day><month>07</month><year>2014</year></pub-date><volume>12</volume><issue>6</issue><fpage>537</fpage><lpage>546</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Харитонов А.Г., Кондрашина Э.А., Барановский А.Ю., Булгакова Т.В., Лапин С.В., Тотолян А.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Харитонов А.Г., Кондрашина Э.А., Барановский А.Ю., Булгакова Т.В., Лапин С.В., Тотолян А.А.</copyright-holder><copyright-holder xml:lang="en">Kharitonov A.G., Kondrashina E.A., Baranovsky A.Y., Bulgakova T.V., Lapin S.V., Totolian A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/469">https://www.mimmun.ru/mimmun/article/view/469</self-uri><abstract/><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>пАНЦА</kwd><kwd>язвенный колит</kwd><kwd>антитела</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>p-ANCA</kwd><kwd>ulcerative colitis</kwd><kwd>antibodies</kwd><kwd>prognosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Лапин C.В., Тотолян А.А. Иммунологическая лабораторная диагностика аутоиммунных заболеваний. -СПб.: Человек, 2010. -272 c.</mixed-citation><mixed-citation xml:lang="en">Лапин C.В., Тотолян А.А. Иммунологическая лабораторная диагностика аутоиммунных заболеваний. -СПб.: Человек, 2010. -272 c.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Никулина И.В., Златкина А.Р., Белоусова Е.А., Румянцев В.Г. Оценка клинико-эпидемиологических показателей воспалительных заболеваний кишечника в Московской области//Российский журнал гастроэнтерологии, гепатологии, колопроктологии. -1997. -№ 2. -C. 67-71.</mixed-citation><mixed-citation xml:lang="en">Никулина И.В., Златкина А.Р., Белоусова Е.А., Румянцев В.Г. Оценка клинико-эпидемиологических показателей воспалительных заболеваний кишечника в Московской области//Российский журнал гастроэнтерологии, гепатологии, колопроктологии. -1997. -№ 2. -C. 67-71.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Abad E. Tural C. Mirapeix E. Cuxart A. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity//J. Autoimmun. -1997. -Vol. 10, N 2. -P. 175-180.</mixed-citation><mixed-citation xml:lang="en">Abad E. Tural C. Mirapeix E. Cuxart A. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity//J. Autoimmun. -1997. -Vol. 10, N 2. -P. 175-180.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bansi D.S., Chapman R.W., Fleming K.A. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease//Eur. J. Gastroenterol. Hepatol. -1996. -Vol. 8, N 9. -P. 881-885.</mixed-citation><mixed-citation xml:lang="en">Bansi D.S., Chapman R.W., Fleming K.A. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease//Eur. J. Gastroenterol. Hepatol. -1996. -Vol. 8, N 9. -P. 881-885.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bansi D.S., Fleming K.A., Chapman R.W. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass//Gut. -1996. -Vol. 38, N 3. -P. 384-389.</mixed-citation><mixed-citation xml:lang="en">Bansi D.S., Fleming K.A., Chapman R.W. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass//Gut. -1996. -Vol. 38, N 3. -P. 384-389.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope//Infect. Immun. -2000. -Vol. 68, N 3. -P. 1542-1548.</mixed-citation><mixed-citation xml:lang="en">Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope//Infect. Immun. -2000. -Vol. 68, N 3. -P. 1542-1548.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cui M.H., Liu Y.L., Yu W.D., Li X.Y. Diagnostic value of antineutrophil cytoplasmic antibodies in patients with ulcerative colitis: a meta-analysis//Zhonghua Yi Xue Za Zhi. -2008. -Vol. 88, N 44. -P. 3116-3119.</mixed-citation><mixed-citation xml:lang="en">Cui M.H., Liu Y.L., Yu W.D., Li X.Y. Diagnostic value of antineutrophil cytoplasmic antibodies in patients with ulcerative colitis: a meta-analysis//Zhonghua Yi Xue Za Zhi. -2008. -Vol. 88, N 44. -P. 3116-3119.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis//N. Engl. J. Med. -1988. -Vol. 318, N 25. -P. 1651-1657.</mixed-citation><mixed-citation xml:lang="en">Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis//N. Engl. J. Med. -1988. -Vol. 318, N 25. -P. 1651-1657.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fekih M., Hlima S., Zitouni M., Matri S., Вoubaker J., Makni S., Azza F. Interest of serologic markers in inflammatory bowel disease. About 105 cases//Tunis. Med. -2007. -Vol. 85, N 10. -P. 821-828.</mixed-citation><mixed-citation xml:lang="en">Fekih M., Hlima S., Zitouni M., Matri S., Вoubaker J., Makni S., Azza F. Interest of serologic markers in inflammatory bowel disease. About 105 cases//Tunis. Med. -2007. -Vol. 85, N 10. -P. 821-828.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gilligan H.M., Bredy B., Brady H.R., Hbert M.J.,Slayter H.S. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming//J. Exp. Med. -1996. -Vol. 184, N 6. -P. 2231-2241.</mixed-citation><mixed-citation xml:lang="en">Gilligan H.M., Bredy B., Brady H.R., Hbert M.J.,Slayter H.S. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming//J. Exp. Med. -1996. -Vol. 184, N 6. -P. 2231-2241.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kallenberg C.G., Brouwer E., Weening J.J., Tervaert J.W. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential//Kidney Int. -1994. -Vol. 46, N 1. -P. 1-15.</mixed-citation><mixed-citation xml:lang="en">Kallenberg C.G., Brouwer E., Weening J.J., Tervaert J.W. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential//Kidney Int. -1994. -Vol. 46, N 1. -P. 1-15.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Leatherman J.W., Sibley R.K., Davies S.F. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to anti-glomerular basement membrane antibody//Am. J. Med. -1982. -Vol. 72, N 3. -P. 401-410.</mixed-citation><mixed-citation xml:lang="en">Leatherman J.W., Sibley R.K., Davies S.F. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to anti-glomerular basement membrane antibody//Am. J. Med. -1982. -Vol. 72, N 3. -P. 401-410.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.H., Cheon J.H., Kim E.S., Chung M.J. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis//Dig. Dis. Sci. -2009. -P. 112-118.</mixed-citation><mixed-citation xml:lang="en">Lee J.H., Cheon J.H., Kim E.S., Chung M.J. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis//Dig. Dis. Sci. -2009. -P. 112-118.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Yu T., Zhao M. The diagnostic significance of antineutrophil cytoplasmic antibodies in ulcerative colitis//Zhonghua. Nei. Ke. Za. Zhi. -1999. -Vol. 38, N 7. -P. 451-454.</mixed-citation><mixed-citation xml:lang="en">Liu X., Yu T., Zhao M. The diagnostic significance of antineutrophil cytoplasmic antibodies in ulcerative colitis//Zhonghua. Nei. Ke. Za. Zhi. -1999. -Vol. 38, N 7. -P. 451-454.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences//Gastroenterology. -2004. -Vol. 126, N 6. -P. 1504-1517.</mixed-citation><mixed-citation xml:lang="en">Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences//Gastroenterology. -2004. -Vol. 126, N 6. -P. 1504-1517.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mallolas J., Esteve M., Rius E., Cabré E., Gassull M.A. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis//Gut. -2000. -Vol. 47, N 1. -P. 74-78.</mixed-citation><mixed-citation xml:lang="en">Mallolas J., Esteve M., Rius E., Cabré E., Gassull M.A. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis//Gut. -2000. -Vol. 47, N 1. -P. 74-78.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mokrowiecka A., Gasiorowska A., Malecka-Panas E. Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases//Pol. Merkur. Lekarski. -2004. -Vol. 17. -N 1. -P. 22-26.</mixed-citation><mixed-citation xml:lang="en">Mokrowiecka A., Gasiorowska A., Malecka-Panas E. Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases//Pol. Merkur. Lekarski. -2004. -Vol. 17. -N 1. -P. 22-26.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mokrowiecka A., Gasiorowska A., Malecka-Panas E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease//Hepatogastroenterology. -2007. -Vol. 54, N 77. -P. 1443-1448.</mixed-citation><mixed-citation xml:lang="en">Mokrowiecka A., Gasiorowska A., Malecka-Panas E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease//Hepatogastroenterology. -2007. -Vol. 54, N 77. -P. 1443-1448.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mulder A.H., Broekroelofs J., Horst G., Limburg P.C., Nelis G.F., Kallenberg C.G. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates//Clin. Exp. Immunol. -1994. -Vol. 95, N 3. -P. 490-497.</mixed-citation><mixed-citation xml:lang="en">Mulder A.H., Broekroelofs J., Horst G., Limburg P.C., Nelis G.F., Kallenberg C.G. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates//Clin. Exp. Immunol. -1994. -Vol. 95, N 3. -P. 490-497.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Osangthamnont C., Manatsathit S., Pongprasopchai S., Viriyataveekul R., Chaihirunkarn S., Leelakusolvong S., Boonyapisit S. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand//J. Gastroenterol. Hepatol. -2001. -Vol. 16, N 8. -P. 866-871.</mixed-citation><mixed-citation xml:lang="en">Osangthamnont C., Manatsathit S., Pongprasopchai S., Viriyataveekul R., Chaihirunkarn S., Leelakusolvong S., Boonyapisit S. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand//J. Gastroenterol. Hepatol. -2001. -Vol. 16, N 8. -P. 866-871.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Papp M., Altorjay I., Lakos G., Tumpek J. Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease Clin.//Vaccine Immunol. -2009. -Vol. 16, N 4. -P. 464-470.</mixed-citation><mixed-citation xml:lang="en">Papp M., Altorjay I., Lakos G., Tumpek J. Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease Clin.//Vaccine Immunol. -2009. -Vol. 16, N 4. -P. 464-470.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Peen E., Almer S., Bodemar G. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease//Gut. -1993. -Vol. 34, N 1. -P. 56-62.</mixed-citation><mixed-citation xml:lang="en">Peen E., Almer S., Bodemar G. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease//Gut. -1993. -Vol. 34, N 1. -P. 56-62.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Preda C.M., Vermeire S., Rutgeerts P., Joosens S., Diculescu M., Marica C., Ciocarlan M., Mirea V., Oproiu A. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis//Rom. J. Gastroenterol. -2005. -Vol. 14, N 4. -P. 357-360.</mixed-citation><mixed-citation xml:lang="en">Preda C.M., Vermeire S., Rutgeerts P., Joosens S., Diculescu M., Marica C., Ciocarlan M., Mirea V., Oproiu A. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis//Rom. J. Gastroenterol. -2005. -Vol. 14, N 4. -P. 357-360.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Roozendaal C., Milligen W., Haagsma E.B., Horst G. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features//Am. J. Med. -1998. -Vol. 105, N 5. -P. 393-399.</mixed-citation><mixed-citation xml:lang="en">Roozendaal C., Milligen W., Haagsma E.B., Horst G. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features//Am. J. Med. -1998. -Vol. 105, N 5. -P. 393-399.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rubin G.P., Hungin A.P., Kelly P.J., Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population//Aliment. Pharmacol. Ther. -2000. -Vol. 14, N 12. -P. 1553-1559.</mixed-citation><mixed-citation xml:lang="en">Rubin G.P., Hungin A.P., Kelly P.J., Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population//Aliment. Pharmacol. Ther. -2000. -Vol. 14, N 12. -P. 1553-1559.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Rump J.A., Schölmerich J., Gross V., Roth M. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease//Immunobiology. -1990. -Vol. 181, N 4-5. -Р. 406-413.</mixed-citation><mixed-citation xml:lang="en">Rump J.A., Schölmerich J., Gross V., Roth M. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease//Immunobiology. -1990. -Vol. 181, N 4-5. -Р. 406-413.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sandborn W., Landers C., Tremaine W. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study//Mayo Clin. Proc. -1996. -Vol. 71, N 5. -P. 431-436.</mixed-citation><mixed-citation xml:lang="en">Sandborn W., Landers C., Tremaine W. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study//Mayo Clin. Proc. -1996. -Vol. 71, N 5. -P. 431-436.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease//J. Allergy Clin. Immunol. -1990. -Vol. 86, N 2. -P. 202-210.</mixed-citation><mixed-citation xml:lang="en">Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease//J. Allergy Clin. Immunol. -1990. -Vol. 86, N 2. -P. 202-210.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Schnabel A., Csernok E., Isenberg D.A., Mrowka C., Gross W.L. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance // Arthritis Rheum. - 1995. - Vol. 38, N 5. - P. 633-637.</mixed-citation><mixed-citation xml:lang="en">Schnabel A., Csernok E., Isenberg D.A., Mrowka C., Gross W.L. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance // Arthritis Rheum. - 1995. - Vol. 38, N 5. - P. 633-637.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Seibold F, Slametschka D., Gregor M., Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis // Gastroenterology. - 1994. - Vol. 107, N 2. - P. 532-536.</mixed-citation><mixed-citation xml:lang="en">Seibold F, Slametschka D., Gregor M., Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis // Gastroenterology. - 1994. - Vol. 107, N 2. - P. 532-536.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Shanahan F., Duerr R.H., Rotter J.I., Yang H., Sutherland L.R. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity//Gastroenterology. -1992. -Vol. 103, N 2. -P. 456-461.</mixed-citation><mixed-citation xml:lang="en">Shanahan F., Duerr R.H., Rotter J.I., Yang H., Sutherland L.R. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity//Gastroenterology. -1992. -Vol. 103, N 2. -P. 456-461.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sobajima J., Ozaki S., Okazaki T. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type//Clin. Exp. Immunol. -1996. -Vol. 105, N 1. -P. 120-124.</mixed-citation><mixed-citation xml:lang="en">Sobajima J., Ozaki S., Okazaki T. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type//Clin. Exp. Immunol. -1996. -Vol. 105, N 1. -P. 120-124.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Sobajima J., Ozaki S., Osakada F., Uesugi H., Shirakawa H., Yoshida M., Nakao K. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2//Clin. Exp. Immunol. -1997. -Vol. 107, N 1. -P. 135-140.</mixed-citation><mixed-citation xml:lang="en">Sobajima J., Ozaki S., Osakada F., Uesugi H., Shirakawa H., Yoshida M., Nakao K. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2//Clin. Exp. Immunol. -1997. -Vol. 107, N 1. -P. 135-140.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Solberg I.C., Lygren I., Cvancarova M., Jahnsen J., Stray N., Sauar J. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease//Inflamm. Bowel. Dis. -2009. -Vol. 15, N3. -P. 406-414.</mixed-citation><mixed-citation xml:lang="en">Solberg I.C., Lygren I., Cvancarova M., Jahnsen J., Stray N., Sauar J. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease//Inflamm. Bowel. Dis. -2009. -Vol. 15, N3. -P. 406-414.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Stange E.F., Travis S.P.L., Vermeire S., Reinisch W. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis Journal of Crohn's and Colitis. -2008. -Vol. 2, N 1. -P. 1-23.</mixed-citation><mixed-citation xml:lang="en">Stange E.F., Travis S.P.L., Vermeire S., Reinisch W. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis Journal of Crohn's and Colitis. -2008. -Vol. 2, N 1. -P. 1-23.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Targan S.R., Landers C.J., Cobb L., MacDermott R.P., Vidrich A. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients//J. Immunol. -1995. -Vol. 155, N 6. -P. 3262-3267.</mixed-citation><mixed-citation xml:lang="en">Targan S.R., Landers C.J., Cobb L., MacDermott R.P., Vidrich A. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients//J. Immunol. -1995. -Vol. 155, N 6. -P. 3262-3267.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Terjung B., Spengler U., Sauerbruch T., Worman H. J. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines//Gastroenterology. -2000. -Vol. 119, N 2. -P. 310-322.</mixed-citation><mixed-citation xml:lang="en">Terjung B., Spengler U., Sauerbruch T., Worman H. J. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines//Gastroenterology. -2000. -Vol. 119, N 2. -P. 310-322.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Uesugi H., Ozaki S., Sobajima J. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases//J. Rheumatol. -1998. -Vol. 25, N 4. -P. 703-709.</mixed-citation><mixed-citation xml:lang="en">Uesugi H., Ozaki S., Sobajima J. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases//J. Rheumatol. -1998. -Vol. 25, N 4. -P. 703-709.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Vergara T., Cofré P., Cifuentes S., Pulgar U., Puebla C., Velasco S. Presence of antineutrophil cytoplasmic antibodies (ANCA) and anti Saccharomyces cerevisiae antibodies (ASCA) among patients with ulcerative colitis//Rev. Med. Chil. -2006. -Vol. 134, N 8. -P. 960-964.</mixed-citation><mixed-citation xml:lang="en">Vergara T., Cofré P., Cifuentes S., Pulgar U., Puebla C., Velasco S. Presence of antineutrophil cytoplasmic antibodies (ANCA) and anti Saccharomyces cerevisiae antibodies (ASCA) among patients with ulcerative colitis//Rev. Med. Chil. -2006. -Vol. 134, N 8. -P. 960-964.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Yang S.K., Hong W.S., Min Y.I. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997//J. Gastroenterol. Hepatol. -2000. -Vol. 15, N 9. -P. 1037-1042.</mixed-citation><mixed-citation xml:lang="en">Yang S.K., Hong W.S., Min Y.I. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997//J. Gastroenterol. Hepatol. -2000. -Vol. 15, N 9. -P. 1037-1042.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Woude F.J. Anticytoplasmic antibodies in Wegener's granulomatosis//Lancet. -1985. -Vol. 6, N 2. -P. 8445-8448.</mixed-citation><mixed-citation xml:lang="en">Woude F.J. Anticytoplasmic antibodies in Wegener's granulomatosis//Lancet. -1985. -Vol. 6, N 2. -P. 8445-8448.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
